American Century Companies’s Zymeworks ZYME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.77M Buy
70,851
+12,019
+20% +$284K ﹤0.01% 2165
2025
Q4
$1.55M Buy
58,832
+7,816
+15% +$170K ﹤0.01% 2177
2025
Q3
$871K Buy
51,016
+19,869
+64% +$284K ﹤0.01% 2343
2025
Q2
$391K Hold
31,147
﹤0.01% 2597
2025
Q1
$371K Sell
31,147
-8,795
-22% -$120K ﹤0.01% 2615
2024
Q4
$585K Buy
+39,942
New +$559K ﹤0.01% 2443
2022
Q1
Sell
-140,548
Closed -$2.3M 2366
2021
Q4
$2.3M Hold
140,548
﹤0.01% 1305
2021
Q3
$4.08M Hold
140,548
﹤0.01% 1081
2021
Q2
$4.88M Sell
140,548
-79,456
-36% -$2.52M ﹤0.01% 999
2021
Q1
$6.95M Buy
220,004
+660
+0.3% +$26.8K 0.01% 860
2020
Q4
$10.4M Buy
219,344
+12
+0% +$557 0.01% 757
2020
Q3
$10.2M Buy
+219,332
New +$7.53M 0.01% 709

Other funds holding ZYME

American Century Companies's ZYME Position: Q1 2026 in Review

American Century Companies increased its Zymeworks (ZYME) stake by 20% in Q1 2026, buying an estimated $284K and bringing the position to 70,851 shares worth $1.77M. The position accounts for ﹤0.01% of the portfolio, ranked #2165.

American Century Companies first reported a position in ZYME in Q3 2020 and has held it in 12 quarters since. The position peaked at $10.4M in Q4 2020. 211 funds tracked by Wall St. Rank hold ZYME as of Q1 2026.

  • American Century Companies held 70,851 shares of Zymeworks worth $1.77M as of Q1 2026.
  • American Century Companies bought 12,019 Zymeworks shares in Q1 2026, an estimated $284K.
  • Zymeworks made up ﹤0.01% of American Century Companies's portfolio in Q1 2026, its #2165 holding.
  • American Century Companies first reported a position in Zymeworks in Q3 2020 and has held it in 12 quarters since.
  • American Century Companies's Zymeworks position peaked at $10.4M in Q4 2020.
  • 211 funds tracked by Wall St. Rank held Zymeworks as of Q1 2026.

Based on American Century Companies's 13F filing for Q1 2026, filed 15 May 2026.